Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Endometriosis
NCT05331053Phase 4Terminated
- Sponsor
- The Pennsylvania State University
- Start
- May 2018
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin in endometriosis, sponsored by The Pennsylvania State University. Started May 2018; status: terminated.
02
Drugs
atorvastatin
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT05331053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05331053.